Skip to content
Disclosery

ORBIMED ADVISORS LLC: ISRG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ISRG, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 157,900 ISRG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 157,900 shares
    Change vs previous 13F -50,800 shares

    1.19% of the 13F portfolio, value $62,793,672.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 208,700 shares
    Change vs previous 13F -54,700 shares

    2.1% of the 13F portfolio, value $96,208,613.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 263,400 shares
    Change vs previous 13F -23,800 shares

    3.05% of the 13F portfolio, value $149,179,224.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 287,200 shares
    Change vs previous 13F -3,800 shares

    3.08% of the 13F portfolio, value $128,444,456.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 291,000 shares
    Change vs previous 13F 0 shares

    3.98% of the 13F portfolio, value $158,132,310.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 291,000 shares
    Change vs previous 13F -110,700 shares

    3.46% of the 13F portfolio, value $144,123,570.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 401,700 shares
    Change vs previous 13F -32,100 shares

    4.35% of the 13F portfolio, value $209,671,332.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 433,800 shares
    Change vs previous 13F not available

    3.9% of the 13F portfolio, value $213,112,926.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).